Profound Medical Corp. Announces Graduation to Toronto Stock Exchange
July 11, 2018 10:10 ET
|
Profound Medical Corp.
TORONTO, July 11, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the...
Profound Medical Announces Annual Meeting of Shareholders Voting Results; Welcomes Two Industry Veterans as Independent Directors to its Board
June 14, 2018 16:30 ET
|
Profound Medical Corp.
TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or the “Company”) (TSXV: PRN) (OTCQX:PRFMF) is pleased to announce the results of the votes on the matters considered at...
Initial Data from Profound Medical’s TACT Pivotal Clinical Trial Presented at AUA 2018
May 21, 2018 11:20 ET
|
Profound Medical Corp.
TORONTO, May 21, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the...
Profound Medical Corp. Announces First Quarter 2018 Financial Results
May 10, 2018 16:02 ET
|
Profound Medical Corp.
TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the...
Profound Medical Corp. Announces Chinese Food and Drug Administration Approval for Sonalleve®
May 09, 2018 16:30 ET
|
Profound Medical Corp.
TORONTO, May 09, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the...
Profound Medical to Release First Quarter 2018 Financial Results on May 10, 2018 – Conference Call to Follow
May 02, 2018 08:00 ET
|
Profound Medical Corp.
TORONTO, May 02, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to offer a therapeutic platform that provides the...
Profound Medical Further Strengthens Management Team with Appointment of Aaron Davidson as Chief Financial Officer and Senior Vice-President of Corporate Development
May 01, 2018 08:30 ET
|
Profound Medical Corp.
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the...
Profound Medical to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference
April 25, 2018 08:30 ET
|
Profound Medical Corp.
TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the...
Accomplished International Medical Device Industry Executive, Ian Heynen, to Lead Profound Medical’s Sales and Marketing Function
April 23, 2018 08:30 ET
|
Profound Medical Corp.
TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the...
Profound Medical Corp. Announces Fourth Quarter and Full Year 2017 Financial Results
March 26, 2018 16:01 ET
|
Profound Medical Corp.
TORONTO, March 26, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the...